Hi E, Join us at the Fierce Biotech Summit in Boston, MA on September 19-20, 2022 to hear how pharma and biotech leaders approach R&D decision-making. You’ll have a chance to learn how companies define value and what drives their motivations as well as steps organizations can take to mitigate risks and chart out a path that will ensure success. Take a look at some of the confirmed speakers including: Andrew Allen, CEO, Gritstone Bio Fabrice Chouraqui, CEO, CellarityGiuseppe Ciaramella, President and Chief Scientific Officer, Beam Therapeutics Kimberly Doggett, Head of Clinical Trial Diversity and Program Delivery Leads, UCBJohn Evans, Chief Executive Officer and Board Member, Beam Therapeutics Molly Gibson, Ph.D, Co-founder, Chief Strategy and Chief Innovation Officer, Generate BiomedicinesAndrew A. Radin, Co-founder and CEO, Aria Pharmaceuticals Thomas Schuetz, CEO, Compass TherapeuticsRachel Zolot Schwartz, MBA, VP, Head of Business Development and Commercial, Volastra Therapeutics |
